Neuberger Berman Group
GSK icon

Neuberger Berman Group’s GSK GSK Stock Holding History

Neuberger Berman Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.72M Buy
67,388
+10,967
+19% +$594K ﹤0.01% 1034
2025
Q4 		$2.77M Sell
56,421
-8,439
-13% -$394K ﹤0.01% 1094
2025
Q3 		$2.8M Buy
64,860
+6,676
+11% +$261K ﹤0.01% 1085
2025
Q2 		$2.23M Buy
58,184
+4,585
+9% +$175K ﹤0.01% 1139
2025
Q1 		$2.08M Buy
53,599
+19,923
+59% +$729K ﹤0.01% 1125
2024
Q4 		$1.14M Sell
33,676
-129
-0.4% -$4.64K ﹤0.01% 1276
2024
Q3 		$1.38M Sell
33,805
-2,464
-7% -$101K ﹤0.01% 1209
2024
Q2 		$1.4M Buy
36,269
+1,958
+6% +$82.4K ﹤0.01% 1184
2024
Q1 		$1.47M Buy
34,311
+1,876
+6% +$77.4K ﹤0.01% 1192
2023
Q4 		$1.2M Buy
32,435
+1,763
+6% +$63.3K ﹤0.01% 1233
2023
Q3 		$1.11M Buy
30,672
+455
+2% +$16.1K ﹤0.01% 1225
2023
Q2 		$1.08M Sell
30,217
-1,041
-3% -$37.3K ﹤0.01% 1228
2023
Q1 		$1.11M Sell
31,258
-884
-3% -$30.9K ﹤0.01% 1220
2022
Q4 		$1.13M Sell
32,142
-4,961
-13% -$165K ﹤0.01% 1209
2022
Q3 		$1.09M Sell
37,103
-1,735
-4% -$65.8K ﹤0.01% 1228
2022
Q2 		$2.11M Sell
38,838
-6,735
-15% -$372K ﹤0.01% 1094
2022
Q1 		$2.48M Sell
45,573
-2,033
-4% -$110K ﹤0.01% 1122
2021
Q4 		$2.53M Buy
47,606
+2,448
+5% +$127K ﹤0.01% 1137
2021
Q3 		$2.14M Sell
45,158
-2,304
-5% -$116K ﹤0.01% 1157
2021
Q2 		$2.34M Buy
47,462
+1,033
+2% +$49.6K ﹤0.01% 1140
2021
Q1 		$2.07M Buy
46,429
+8,739
+23% +$397K ﹤0.01% 1147
2020
Q4 		$1.73M Sell
37,690
-45,150
-55% -$2.07M ﹤0.01% 1137
2020
Q3 		$3.9M Sell
82,840
-281
-0.3% -$14.1K ﹤0.01% 911
2020
Q2 		$4.25M Sell
83,121
-21,529
-21% -$1.1M 0.01% 857
2020
Q1 		$4.97M Sell
104,650
-164,605
-61% -$8.78M 0.01% 789
2019
Q4 		$15.8M Buy
269,255
+159,958
+146% +$8.9M 0.02% 651
2019
Q3 		$5.83M Sell
109,297
-4,473
-4% -$230K 0.01% 818
2019
Q2 		$5.69M Sell
113,770
-3,312
-3% -$166K 0.01% 847
2019
Q1 		$6.12M Buy
117,082
+9,856
+9% +$493K 0.01% 814
2018
Q4 		$5.12M Sell
107,226
-2,444
-2% -$120K 0.01% 844
2018
Q3 		$5.51M Sell
109,670
-21,673
-17% -$1.1M 0.01% 891
2018
Q2 		$6.62M Sell
131,343
-3,679
-3% -$185K 0.01% 872
2018
Q1 		$6.59M Buy
135,022
+11,831
+10% +$551K 0.01% 845
2017
Q4 		$5.46M Sell
123,191
-670,155
-84% -$31M 0.01% 867
2017
Q3 		$40.3M Buy
793,346
+12,528
+2% +$636K 0.05% 443
2017
Q2 		$42.1M Buy
780,818
+3,388
+0.4% +$181K 0.05% 420
2017
Q1 		$41M Buy
777,430
+255,251
+49% +$12.9M 0.05% 427
2016
Q4 		$25.1M Sell
522,179
-683,420
-57% -$33.8M 0.03% 528
2016
Q3 		$65M Sell
1,205,599
-1,806
-0.1% -$99K 0.09% 317
2016
Q2 		$65.4M Sell
1,207,405
-68,747
-5% -$3.62M 0.09% 300
2016
Q1 		$64.7M Buy
1,276,152
+219,228
+21% +$10.9M 0.09% 308
2015
Q4 		$53.3M Sell
1,056,924
-138,230
-12% -$7.05M 0.07% 353
2015
Q3 		$57.4M Buy
1,195,154
+101,399
+9% +$5.28M 0.07% 328
2015
Q2 		$56.9M Buy
1,093,755
+167,174
+18% +$9.41M 0.06% 383
2015
Q1 		$53.5M Buy
926,581
+256,226
+38% +$14.7M 0.06% 407
2014
Q4 		$35.8M Buy
670,355
+176,338
+36% +$9.87M 0.04% 501
2014
Q3 		$28.4M Buy
494,017
+359,386
+267% +$22M 0.03% 569
2014
Q2 		$9M Sell
134,631
-2,223
-2% -$150K 0.01% 855
2014
Q1 		$9.14M Sell
136,854
-6,799
-5% -$460K 0.01% 818
2013
Q4 		$9.59M Sell
143,653
-41,191
-22% -$2.67M 0.01% 799
2013
Q3 		$11.6M Buy
184,844
+31,904
+21% +$2.05M 0.01% 753
2013
Q2 		$9.55M Buy
+152,940
New +$9.71M 0.01% 765

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Neuberger Berman Group's GSK Position: Q1 2026 in Review

Neuberger Berman Group increased its GSK (GSK) stake by 19% in Q1 2026, buying an estimated $594K and bringing the position to 67,388 shares worth $3.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1034.

Neuberger Berman Group first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $65.4M in Q2 2016. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Neuberger Berman Group held 67,388 shares of GSK worth $3.72M as of Q1 2026.
  • Neuberger Berman Group bought 10,967 GSK shares in Q1 2026, an estimated $594K.
  • GSK made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #1034 holding.
  • Neuberger Berman Group first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
  • Neuberger Berman Group's GSK position peaked at $65.4M in Q2 2016.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.